Skip to main content

People in the News: Clare Rebbeck, Charles Vanderburg, Sara Larriba, Muthuswamy Balasubramanyam, Johannes Grillari, Serena Lucotti, Viviana Bumaschny, Richard Keijzer, Carolyn Klinge, Hanjoong Jo

Premium

Exiqon announced 10 winners of its 2012 grant program, which provides microRNA researchers with awards that can be used to purchase Exiqon miRNA products and services.

This year's winner's include Cold Spring Harbor Laboratory's Clare Rebbeck; Harvard Medical School's Charles Vanderburg; Bellvitge Biomedical Research Institute's Sara Larriba; and Madras Diabetes Research Foundation's Muthuswamy Balasubramanyam.

Also winning grants are Johannes Grillari of Vienna's University of Natural Resources and Life Sciences; the Institute of Clinical Physiology's Serena Lucotti; the University of Buenos Aires' Viviana Bumaschny; Richard Keijzer of the University of Manitoba: Carolyn Klinge of the University of Louisville School of Medicine; and Hanjoong Jo of Emory University.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.